Holen Sie sich die Stockscreener-App
102.73
5.96%
-6.51
Vorhandelsmarkt:
101.73
-1.00
-0.97%
Schlusskurs vom Vortag:
$109.24
Offen:
$108.17
24-Stunden-Volumen:
684.53K
Relative Volume:
0.84
Marktkapitalisierung:
$2.61B
Einnahmen:
$302.00K
Nettoeinkommen (Verlust:
$-117.10M
KGV:
-9.23
EPS:
-11.13
Netto-Cashflow:
$-129.13M
1W Leistung:
+2.75%
1M Leistung:
+0.73%
6M Leistung:
+373.63%
1J Leistung:
+684.80%
1-Tages-Spanne:
$102.26
$109.37
1-Wochen-Bereich:
$98.25
$113.00
52-Wochen-Spanne:
$12.74
$121.21
Cidara Therapeutics Inc Stock (CDTX) Company Profile
Firmenname
Cidara Therapeutics Inc
Sektor
Branche
Telefon
858-752-6170
Adresse
6310 NANCY RIDGE DRIVE, SAN DIEGO, CA
Vergleichen Sie CDTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CDTX
Cidara Therapeutics Inc
|
102.73 | 2.77B | 302.00K | -117.10M | -129.13M | -11.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Cidara Therapeutics Inc Stock (CDTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-16 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-10-10 | Eingeleitet | JP Morgan | Overweight |
| 2025-06-18 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-03-12 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2025-01-27 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2024-12-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-11-08 | Eingeleitet | Guggenheim | Buy |
| 2024-08-14 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2021-12-03 | Fortgesetzt | H.C. Wainwright | Buy |
| 2021-09-22 | Hochstufung | WBB Securities | Buy → Strong Buy |
| 2021-03-04 | Eingeleitet | Aegis Capital | Buy |
| 2019-09-04 | Hochstufung | Wedbush | Neutral → Outperform |
| 2018-07-26 | Eingeleitet | Citigroup | Buy |
| 2017-04-21 | Eingeleitet | Raymond James | Strong Buy |
| 2017-04-17 | Bestätigt | H.C. Wainwright | Buy |
| 2017-04-12 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2017-04-11 | Fortgesetzt | Wedbush | Outperform |
| 2017-02-22 | Bestätigt | H.C. Wainwright | Buy |
| 2017-02-22 | Hochstufung | WBB Securities | Sell → Hold |
| 2016-12-21 | Fortgesetzt | Leerink Partners | Outperform |
| 2016-12-19 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-09-23 | Herabstufung | WBB Securities | Hold → Sell |
| 2015-10-09 | Hochstufung | WBB Securities | Sell → Hold |
| 2015-05-11 | Eingeleitet | Jefferies | Buy |
| 2015-05-11 | Eingeleitet | Leerink Partners | Outperform |
| 2015-05-11 | Eingeleitet | Needham | Buy |
| 2015-05-11 | Eingeleitet | Wedbush | Outperform |
| 2015-04-23 | Eingeleitet | WBB Securities | Sell |
Alle ansehen
Cidara Therapeutics Inc Aktie (CDTX) Neueste Nachrichten
Applying big data sentiment scoring on Cidara Therapeutics Inc.CPI Data & Weekly Setup with High ROI Potential - newser.com
Should you wait for a breakout in Cidara Therapeutics Inc.Weekly Risk Summary & Daily Price Action Insights - newser.com
Evaluating Cidara Therapeutics Inc. with trendline analysisMarket Volume Report & Daily Entry Point Trade Alerts - newser.com
Can Cidara Therapeutics Inc. stock hit analyst price targetsMarket Activity Report & Safe Capital Allocation Plans - newser.com
Citizens Capital Markets Initiates Coverage of Cidara Therapeutics (CDTX) with Market Outperform Recommendation - MSN
Cidara jumps after expedited late-stage trial plan for flu therapy - MSN
Is Cidara Therapeutics Inc a good long term investmentPrice Momentum Alerts & Free Trading Psychology Coaching - earlytimes.in
Will Cidara Therapeutics Inc. stock outperform Dow Jones indexQuarterly Profit Report & Risk Managed Investment Entry Signals - newser.com
Will Cidara Therapeutics Inc. stock outperform international peersMarket Risk Report & Safe Entry Momentum Tips - newser.com
Using data models to predict Cidara Therapeutics Inc. stock movementJuly 2025 Fed Impact & Long-Term Safe Investment Ideas - newser.com
Signal strength of Cidara Therapeutics Inc. stock in tech scannersStock Surge & AI Driven Price Predictions - newser.com
How Cidara Therapeutics Inc. stock benefits from strong dollarMarket Rally & Safe Entry Trade Reports - newser.com
Does Cidara Therapeutics Inc. stock trade at a discount to peersRecession Risk & Low Risk Entry Point Tips - newser.com
What to do if you’re stuck in Cidara Therapeutics Inc.July 2025 Catalysts & AI Forecast for Swing Trade Picks - newser.com
How risky is Cidara Therapeutics Inc. stock nowMarket Performance Summary & Capital Protection Trading Alerts - newser.com
Will Cidara Therapeutics Inc. stock deliver long term returns2025 Trading Volume Trends & Comprehensive Market Scan Insights - newser.com
How Cidara Therapeutics Inc. stock compares to growth peersQuarterly Trade Report & Proven Capital Preservation Methods - newser.com
Cidara Therapeutics (CDTX) Price Target Increased by 24.94% to 167.79 - MSN
JMP Securities Maintains Cidara Therapeutics (CDTX) Market Outperform Recommendation - MSN
AlphaQuest LLC Makes New Investment in Cidara Therapeutics, Inc. $CDTX - MarketBeat
Jennison Associates LLC Invests $2.40 Million in Cidara Therapeutics, Inc. $CDTX - MarketBeat
Cidara Therapeutics, Inc. (CDTX) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Should you hold or exit Cidara Therapeutics Inc. nowMarket Rally & Fast Exit Strategy with Risk Control - newser.com
Cidara Therapeutics (CDTX): Assessing Valuation After FDA Breakthrough Therapy Nod and New BARDA Support - Sahm
Cidara Therapeutics (CDTX) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
What hedge fund moves indicate for Cidara Therapeutics Inc. (20D0) stockEarnings Summary Report & Daily Stock Momentum Reports - newser.com
Published on: 2025-10-31 05:10:02 - newser.com
Why Cidara Therapeutics Inc. stock is in analyst buy zone2025 Bull vs Bear & Consistent Income Trade Recommendations - newser.com
How to escape a deep drawdown in Cidara Therapeutics Inc.2025 Historical Comparison & Stock Portfolio Risk Management - newser.com
Is Cidara Therapeutics Inc. forming a bottoming base2025 Risk Factors & Safe Capital Growth Trade Ideas - newser.com
Using Ichimoku Cloud for Cidara Therapeutics Inc. technicalsJuly 2025 Short Interest & AI Powered Buy/Sell Recommendations - newser.com
Finanzdaten der Cidara Therapeutics Inc-Aktie (CDTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):